These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21996984)

  • 1. Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease.
    Basturk T; Unsal A; Ulas T
    Minerva Urol Nefrol; 2011 Dec; 63(4):287-92. PubMed ID: 21996984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.
    Dogan E; Erkoc R; Sayarlioglu H; Soyoral Y; Dulger H
    Ren Fail; 2008; 30(4):407-10. PubMed ID: 18569914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.
    Massart A; Debelle FD; Racapé J; Gervy C; Husson C; Dhaene M; Wissing KM; Nortier JL
    Am J Kidney Dis; 2014 Nov; 64(5):696-705. PubMed ID: 24856872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
    Molina P; Górriz JL; Molina MD; Peris A; Beltrán S; Kanter J; Escudero V; Romero R; Pallardó LM
    Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit.
    Premaor MO; Scalco R; da Silva MJ; Froehlich PE; Furlanetto TW
    J Bone Miner Metab; 2008; 26(6):603-8. PubMed ID: 18979160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.
    Garcia-Lopes MG; Pillar R; Kamimura MA; Rocha LA; Canziani ME; Carvalho AB; Cuppari L
    Ann Nutr Metab; 2012; 61(1):74-82. PubMed ID: 22889840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
    Zitt E; Sprenger-Mähr H; Mündle M; Lhotta K
    BMC Nephrol; 2015 Aug; 16():128. PubMed ID: 26238347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
    Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease.
    Kari JA; Eldesoky SM; Bagdadi OT
    Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency.
    Diamond T; Wong YK; Golombick T
    Osteoporos Int; 2013 Mar; 24(3):1101-5. PubMed ID: 22422304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease.
    Yadav AK; Kumar V; Kumar V; Banerjee D; Gupta KL; Jha V
    J Bone Miner Res; 2018 Mar; 33(3):404-409. PubMed ID: 29044707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
    Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease.
    Kim SM; Choi HJ; Lee JP; Kim DK; Oh YK; Kim YS; Lim CS
    J Ren Nutr; 2014 Jan; 24(1):20-5. PubMed ID: 24216258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecalciferol supplementation reduces soluble Klotho concentration in hemodialysis patients.
    Hryszko T; Rydzewska-Rosołowska A; Goździkiewicz J; Brzósko S; Koc-Żórawska E; Zelazowska-Rutkowska B; Myśliwiec M
    Pol Arch Med Wewn; 2013; 123(6):277-81. PubMed ID: 23673970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of a high loading dose of cholecalciferol to correct hypovitaminosis d in patients with inflammatory/autoimmune rheumatic diseases.
    Sainaghi PP; Bellan M; Nerviani A; Sola D; Molinari R; Cerutti C; Pirisi M
    J Rheumatol; 2013 Feb; 40(2):166-72. PubMed ID: 23242183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.